Rheumatoid arthritis: getting the facts straight about methotrexate (webinar)

Learning outcomes

Upon completion of this module the learner will be able to:

Describe the importance of an integrated approach in optimising the early initiation and persistence of low-dose methotrexate used for RA.
Determine the urgency of any referral based on patient presenting clinical features, key test results, prognostic features and specialist advice if required.
Explain to patients the role of low-dose methotrexate in RA and dispel common myths about methotrexate therapy.
Outline how health professionals can agree on a shared care plan to monitor DMARD use and manage patient CVD associated risk and lifestyle factors.
Describe the role of corticosteroids in the management of rheumatoid arthritis including recommended dosage and strategies which limit any drug adverse effects.